ACE2 and systemic lupus erythematosus: Anti-ACE2 antibodies that inhibit the anti-inflammatory and anti-fibrotic effects of ACE2 have been described in connective tissue diseases with constrictive vasculopathies, such as SSc, SLE and mixed connective tissue disease (MCTD) (51, 52).